Cargando…
Integration of genomic variants and bioinformatic-based approach to drive drug repurposing for multiple sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease in the central nervous system (CNS) marked by inflammation, demyelination, and axonal loss. Currently available MS medication is limited, thereby calling for a strategy to accelerate new drug discovery. One of the strategies to discover new dru...
Autores principales: | Afief, Arief Rahman, Irham, Lalu Muhammad, Adikusuma, Wirawan, Perwitasari, Dyah Aryani, Brahmadhi, Ageng, Cheung, Rocky |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9464879/ https://www.ncbi.nlm.nih.gov/pubmed/36105612 http://dx.doi.org/10.1016/j.bbrep.2022.101337 |
Ejemplares similares
-
Genomic variants-driven drug repurposing for tuberculosis by utilizing the established bioinformatic-based approach
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
The use of genomic variants to drive drug repurposing for chronic hepatitis B
por: Irham, Lalu Muhammad, et al.
Publicado: (2022) -
Identification of Hub Genes and Potential Biomarkers for Childhood Asthma by Utilizing an Established Bioinformatic Analysis Approach
por: Santri, Ichtiarini Nurullita, et al.
Publicado: (2022) -
Drug Repurposing for Atopic Dermatitis by Integration of Gene Networking and Genomic Information
por: Adikusuma, Wirawan, et al.
Publicado: (2021) -
Identification of druggable genes for multiple myeloma based on genomic information
por: Satria, Rahmat Dani, et al.
Publicado: (2023)